We report a case of a 5-year-old boy with intractable partial seizures who developed a transient hemiparesis, worsening of the electroencephalogram (EEG) and a change in his seizure pattern with increased seizure frequency after receiving topiramate (TPM). Symptoms resolved within a month after TPM was discontinued. Clinicians need to be aware that TPM use may occasionally be associated with focal motor weakness and exacerbation of seizures.
INTRODUCTION
Topiramate (TPM) is a sulfamate-substituted monosaccharide with antiepileptic properties. It has multiple mechanisms of action that suggest a broad spectrum of anticonvulsant activity (including sodium channel blockade, attenuation of excitatory responses induced by kainate and enhancement of inhibition mediated by gamma-aminobutyric acid) 1 . It is effective as adjunctive therapy for adults and children ages 2-16 years with partial onset seizures and primary generalized tonic-clonic seizures [2] [3] [4] . The most common side effects of TPM are somnolence, fatigue, weight loss, difficulty with memory and nervousness 5 . Transient hemiparesis in adults, during TPM therapy has been reported recently 6 . We report a child with focal epilepsy who developed transient hemiparesis and a change in seizure pattern with worsening of the EEG, during treatment with TPM.
CASE REPORT
A 5.5 year-old boy started having seizures at 2.5 years of age that were characterized by 5-10 second episodes of twitching of the right side of the face associated with his head dropping backwards and inability to talk, without clear-cut postictal change. On a few occasions, the seizures were more prolonged with right arm weakness followed by a postictal Todd's paresis of the right arm, lasting for a few minutes. There were no generalized tonic-clonic seizures. There was no history of febrile seizures or head trauma. Family history was negative for epilepsy. He was born at term following uncomplicated pregnancy and delivery. Neurological examination and developmental milestones were normal. Routine laboratory studies and urine screen for aminoacids and organic acids were normal. Head magnetic resonance imaging (MRI) showed a small island of heterotopic gray matter in the white matter adjacent to the atrium of the left lateral ventricle with subtle enlargement of the ventricle in that area. There was no overlying cortical abnormality. His initial EEG showed epileptiform discharges arising from the left centro-temporal head regions.
He was started on phenytoin (PHT) following the first seizure. The seizures were uncontrolled on PHT and on subsequent carbamazepine (CBZ) monotherapy. Valproic acid (VPA) was added to the CBZ.
He was evaluated at 5 years of age for frequent, prolonged right focal seizures whilst on VPA (59 mg kg −1 day −1 , level 80 µg ml −1 ), and CBZ (23 mg kg −1 day −1 , level 5.7 µg ml −1 ). EEG showed focal independent bilateral centrotemporal epileptiform discharges, being higher in amplitude over the right side. TPM was added to his regimen at 1 mg kg −1 day −1 , with dose increments of 1 mg kg −1 day −1 every 2 weeks. He became seizure free at a TPM dose of approximately 5 mg kg −1 day −1 . Six months later he began having recurrent seizures, including a type that mother had not previously noted. These new seizures were described as brief episodes of staring associated with fluttering of the eyelids and head nodding, lasting 2-3 seconds without associated post-ictal changes. Because of these breakthrough seizures, the dose of TPM was gradually increased. CBZ was weaned. While the TPM was being maximized, he continued to have several seizures of each type per day. Parents also reported changes in his behavior. He appeared constantly tired, had lost weight and had difficulty chewing and swallowing. They felt that he had regressed with deterioration of fine motor skills and nocturnal enuresis. He was clumsy and took longer than usual to perform previously learned motor tasks. He was less interactive, with reduced speech and had difficulty expressing himself. He was now noted to have persistent weakness of the right arm. Examination revealed an alert 5.5 year-old boy, who preferred to use his left hand. He had slurred speech and answered questions very slowly in two to three word sentences. He had difficulty with word finding. Cranial nerves were normal. His right arm was weak with 4/5 power. Deep tendon reflexes were symmetric with bilateral flexor plantar responses. He had mild truncal ataxia and bilateral intention tremor. He had decreased associated movements of the right arm while walking. Occupational and speech therapy were started. EEG at this time (on VPA at a dose of 52 mg kg −1 day −1 , with a level of 63 µg ml −1 and TPM 9 mg kg −1 day −1 with a level of 6.1 µg ml −1 ), showed independent left and right centro-temporal epileptiform discharges as well as very frequent bisynchronous high-amplitude fronto-centrally dominant arrhythmic spike-slow wave discharges at 2-3 cps of variable duration, often showing random asymmetry. There was diffuse slowing of the background (Fig. 1) . A repeat MRI with and without gadolinium did not show any significant change from the previous one.
Ethosuximide (ETX) was added and TPM was weaned. He became seizure free. The hemiparesis, dysarthria, difficulty with word finding and ataxia had resolved at a follow-up visit 1 month after discontinuation of TPM. Follow-up EEG, 1 month after TPM was discontinued, showed only occasional left centro-temporal epileptiform discharges, without the bisynchronous epileptiform discharges seen earlier (Fig. 2) . He has remained seizure free for the past 2 years on a combination of VPA and ETX.
DISCUSSION
This is the first report of a child with transient hemiparesis linked to TPM therapy. Our patient did not have any pre-existing focal neurologic deficits and had history of intermittent right arm weakness (Todd's paresis) seen only postictally. However, he did develop a persistent weakness of that extremity whilst on TPM, which resolved once the drug was discontinued. His MRI did show a small focal area of heterotopic gray matter in the white matter adjacent to the atrium of the left lateral ventricle but anatomically, this would not account for the right arm weakness. There is only one other report of two adults who developed transient hemiparesis during TPM use 6 . However, both of them had preexisting neurological dysfunction. One was a 41-yearold man with cerebral palsy, left hemispheric atrophy and right hemiparesis who developed a transient left hemiparesis whilst taking TPM. The second patient was a 59-year-old woman with focal seizures due to herpes simplex encephalitis and resultant left anterior temporal lobe infarction, who developed a transient right hemiparesis on TPM therapy.
The mechanism for the development of the hemiparesis in our patient is unclear. It is unlikely that this hemiparesis represented a Todd's paresis or a focal status epilepticus (epilepsia partials continua), since it was persistent over several weeks and was not associated with ictal EEG changes. It could be possible that the global encephalopathy associated with the use of TPM was responsible in unmasking a pre-existent compensated focal deficit.
We believe that TPM use was associated with worsening of the EEG abnormalities in our patient with well documented focal epilepsy, resulting in the appearance of paroxysms of bisynchronous spikewave discharges which were arrhythmic and often asymmetrical (Fig. 1) . It is unclear whether these abnormalities represented secondary bilateral synchrony or a generalized epileptogenic dysfunction. These findings were associated with the appearance of a new type of seizure which had the clinical semiology of absence seizures that responded to ETX. It is possible that these seizures were a variant of some kind of the pre-existing partial seizures. Unfortunately, a video/EEG recording was not performed, which would have further clarified whether this new type of seizures were in fact absence seizures. The EEG abnormalities resolved when TPM was weaned (Fig. 2) . Some anticonvulsants are known to provoke certain types of seizures. PHT and CBZ are known to worsen absence seizures 7, 8 . Tiagabine was recently reported to cause nonconvulsive statusepilepticus with EEG documented generalized spikewave discharges 9, 10 .
Our patient also had other side-effects attributable to TPM such as fatigue, apathy, weight loss with reduced appetite and dysphagia, psychomotor slowing with deterioration of fine motor skills, language problems, difficulty with word finding, ataxia, and nocturnal enuresis.
It is important to recognize that focal motor weakness may be seen during treatment with TPM. In addition, TPM, like some other anticonvulsants, may cause worsening of seizures in some individuals. Close clinical and EEG monitoring is essential for early detection and prompt withdrawal of the drug in such cases.
